Cite
HARVARD Citation
Ewara, E. et al. (n.d.). SAT0209 A comparative real-world utilization patterns of innovator and biosimilar infliximab in a treatment naÏve and switch population from germany: a prescription claims analysis. Annals of the rheumatic diseases. p. 965. [Online].